Dmitri Wiederschain

Dmitri Wiederschain

Company: Crossbow Therapeutics

Job title: Chief Scientific Officer


Accessing Intracellular Cancer Targets via Potent & Specific TCR Mimetic (TCRm)-Based T Cell Engagers 12:30 pm

Previously unreachable target classes amenable to TCRm-based T Cell engagers Differences and similarities between soluble TCR and TCRm-based T cell engager approaches Unique challenges and opportunities in developing TCRm-based T Cell EngagersRead more

day: Conference Day 2

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.